Abstract 17688: Soluble ST2 Concentration Predicts 1-Year Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)
Bernhard Wernly(Paracelsus Medical University), Alexander Lauten(German Centre for Cardiovascular Research), Mathias Ausserwinkler(Paracelsus Medical University), Uta C. Hoppe(Baker Heart and Diabetes Institute), Ulf Landmesser(University of Zurich), Sarah Eder(Paracelsus Medical University), Michael Lichtenauer(University of Salzburg), Hans‐Reiner Figulla(Friedrich Schiller University Jena), Christian Jung(Heinrich Heine University Düsseldorf)
Circulation
November 11, 2016
Cited by 0
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k